Page 115 - Read Online

Miller et al. J Cancer Metastasis Treat 2019;5:68 I http://dx.doi.org/10.20517/2394-4722.2019.001 Page 9 of 11

REFERENCES
1. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, et al. Definition and classification of cancer cachexia: an international consensus.
Lancet Oncol 2011;12:489-95.
2. Fearon KC, Voss AC, Hustead DS; Cancer Cachexia Study Group. Definition of cancer cachexia: effect of weight loss, reduced food intake,
and systemic inflammation on functional status and prognosis. Am J Clin Nutr 2006;83:1345-50.
3. Porporato PE. Understanding cachexia as a cancer metabolism syndrome. Oncogenesis 2016;5:e200.
4. Douglas E, McMillan DC. Towards a simple objective framework for the investigation and treatment of cancer cachexia: the Glasgow
Prognostic Score. Cancer Treat Rev 2014;40:685-91.
5. Arends J, Bachmann P, Baracos V. ESPEN guidelines on nutrition in cancer patients. Clin Nutr 2017;36:11-48.
6. Laird B, Fallon M. Treating cancer cachexia: an evolving landscape. Ann Oncol 2017;28:2055-6.
7. Shurin MR. Cancer as an immune-mediated disease. ImmunoTargets Ther 2012;1:1-6.
8. de Matos-Neto E, Lima J, dePeriera W, Figuerêdo R, Riccardi D, et al. Systemic inflammation in cachexia - is tumor cytokine expression
profile the culprit? Front Immunol 2015;6:1-11.
9. Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH. Cancer-associated cachexia. Nat Rev Dis Primer 2018;4:17105.
10. Tracey K, Lowry SF, Cerami A. Cachectin: a hormone that triggers acute shock and chronic cachexia. J Infect Dis 1988;157:413-20.
11. Sharma M, Kambadur R, Sriram S, Lokireddy S, McFarlane CD. Molecular targets of cancer cachexia: Opportunities for pharmanutritional
approaches. PharmaNutrition 2014;2:126-8.
12. Sherry BA, Gelin J, Fong Y, Marano M, Wei H, et al. Anticachectin/tumor necrosis factor-alpha antibodies attenuate development of
cachexia in tumor models. FASEB J 1989;3:1956-62.
13. Hayden MS, Ghosh S. Regulation of NF-κB by TNF family cytokines. Semin Immunol 2014;26:253-66.
14. Cawthorn W, Sethi J. TNF-α and adipocyte biology. FEBS Lett 2008;9:117-31.
15. Noguchi Y, Vydelingum N, Younes R, Fried S, Brennan M. Tumor-induced alterations in tissue lipoprotein lipase activity and mRNA levels.
Cancer Res 1991;51:863-9.
16. Torelli G, Meguid M, Moldawer LL, Edwards C, Kim H, et al. Use of recombinant human soluble TNF receptor in anorectic tumor-bearing
rats. Am J Physiol 1999;277:850-5.
17. Llovera M, García-Martínez C, Lopez-Soriano J, Agell N, Lopez-Soriano FJ, et al. Protein turnover in skeletal muscle of tumour-bearing
mice overexpressing the soluble TNF receptor-1. Cancer Lett 1998;130:19-27.
18. Yu Z, Li P, Hannink M, Stamler J, Yan Z. Fiber type-specific nitric oxide protects oxidative myofibers against cachectic stimuli. PLoS One
2008;3:e2086.
19. Tisdale MJ. Biology of cachexia. J Natl Cancer Inst 1997;89:1763-73.
20. Thompson M, Cooper S, Parry B, Tuckey J. Increased expression of the mRNA for hormone-sensitive lipase in adipose tissue of cancer
patients. Biochim Biophys Acta 1993;1180:236-42.
21. Karayiannakis A, Syrigos K, Polychronidis A, Pitiakoudis M, Bounovas A, et al. Serum levels of tumor necrosis factor-α and nutritional
status in pancreatic cancer patients. Anticancer Res 2001;21:1355-8.
22. Maltoni M, Fabbri L, Nanni O, Scarpi E, Pezzi L, et al. Serum levels of tumour necrosis factor alpha and other cytokines do not correlate
with weight loss and anorexia in cancer patients. Support Care Cancer 1997;5:130-5.
23. Hou YC, Wang CJ, Chen HY, Wang HC, Tung HL, et al. Elevated serum interleukin-8 level correlates with cancer-related cachexia and
sarcopenia: an indicator for pancreatic cancer outcomes. J Clin Med 2018;7:502.
24. Haller O, Kochs G, Weber F. The interferon response circuit: Induction and suppression by pathogenic viruses. Virology 2006;344:119-30.
25. Mah A, Cooper M. Metabolic regulation of natural killer cell IFN-γ production. Crit Rev Immunol 2016;36:131-47.
26. Stanton S, Disis M. Clinical significance of tumor-infiltrating lymphocytes in breast cancer. J Immunother Cancer 2016;4:59.
27. Palata-Salaman C. Interferons and central regulation of feeding. Am J Physiol 1993;263:1222-7.
28. Matthys P, Dukmans R, Proost P, Van Damme J, Heremans H, et al. Severe cachexia in mice inoculated with interferon-γ-producing tumor
cells. Int J Cancer 1991;49:77-82.
29. Matthys P, Heremans H, Opdenakker G, Billiau A. Anti-interferon-gamma antibody treatment, growth of Lewis lung tumours in mice and
tumour associated cachexia. Eur J Cancer 1991;27:182-7.
30. Langstein H, Doherty G, Fraker D, Buresh C, Norton JA. The roles of gamma-interferon and tumor necrosis factor alpha in an experimental
rat model of cancer cachexia. Cancer Res 1991;51:2302-6.
31. Gregoire F, Broux N, Hauser N, Heremans H, Van Damme J, et al. Interferon-gamma and interleukin-1 beta inhibit adipoconversion in
cultured rodent preadipocytes. J Cell Physiol 1992;151:300-9.
32. Yeh S, Schuster M. Geriatric cachexia: the role of cytokines. Am J Clin Nutr 1999;70:183-97.
33. Dinarello C. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011;117:3720-32.
34. Hardardottir I, Doerrler W, Feingold K, Grunfeld C. Cytokines stimulate lipolysis and decrease lipoprotein lipase activity in cultured fat
cells by a prostaglandin independent mechanism. Biochem Biophys Res Commun 1992;186:237-43.
35. McCarthy H, Dryden S, Williams G. Interleukin-1 beta-induced anorexia and pyrexia in rat: relationship to hypothalamic neuropeptide Y.
Am J Physiol 1995;269:852-7.
36. Sato T, Laviano A, Meguid M, Chen C, Rossi Fanelli F, et al. Involvement of plasma leptin, insulin and free tryptophan in cytokine-induced
anorexia. Clin Nutr 2003;22:139-46.
37. Costelli P, Llovera M, Carbo N, García-Martínez C, Lopez-Sorianoq F, et al. Interleukin-1 receptor antagonist (IL-1ra) is unable to reverse
cachexia in rats bearing an ascites hepatoma (Yoshida AH-130). Cancer Lett 1995;95:33-8.
38. Strassmann G, Masui Y, Chizzonite R, Fong M. Mechanisms of experimental cancer cachexia. Local involvement of IL-1 in colon-26
tumor. J Immunol 1993;150:2341-5.